Multiple Sclerosis Trial, Recruiting (NCT07424027)

Multiple Sclerosis Trial, Recruiting NCT07424027 Sponsor: The Cleveland Clinic Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07424027 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You must already be enrolled in and meet all the entry requirements of a related study called CAVS-MS.
You must have taken part in the CAVS-MS study and completed your visits at the 24-month mark.
You must be able and willing to sign a consent form agreeing to take part in the study.

Who may not be able to join:

You may not be able to join if you have metal in your body or metal implants that are not safe to use with an MRI scanner.
You may not be able to join if you are unable to go through an MRI scan because of fear of small, enclosed spaces (claustrophobia) or because of uncontrollable movements such as tremors.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Ontaneda, MD, PHD, The Cleveland Clinic

Phone: 216-445-9845

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07424027

Sponsor: The Cleveland Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 216-445-9845

More information: https://clinicaltrials.gov/study/NCT07424027

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You must already be enrolled in and meet all the entry requirements of a related study called CAVS-MS.
You must have taken part in the CAVS-MS study and completed your visits at the 24-month mark.
You must be able and willing to sign a consent form agreeing to take part in the study.

Who may not be able to join:

You may not be able to join if you have metal in your body or metal implants that are not safe to use with an MRI scanner.
You may not be able to join if you are unable to go through an MRI scan because of fear of small, enclosed spaces (claustrophobia) or because of uncontrollable movements such as tremors.

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Cleveland Clinic

Registry

ClinicalTrials.gov

Start date

7 October 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

MRI Outcomes- CVS; MRI Outcomes- PRL; Clinical Outcomes- Diagnosis of MS by 2017 Diagnostic Criteria; Clinical Outcomes- EDSS; Clinical Outcomes- Multiple Sclerosis Functional Composite (MSFC-4)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov